Giladi O.; Bagnato G.; Gentilini M.; Shimony S.; Pasvolsky O.; Berger T.; Itchaki G.; Raanani P.; Broccoli A.; Stefoni V.S.; Lolli G.; Argnani L.; Zinzani P.L.; Gurion R., ABCL-298 Diffuse Large B-Cell Lymphoma During the Covid-19 Pandemic in Two Tertiary Centers: The Israeli/Italian Study, «CLINICAL LYMPHOMA MYELOMA & LEUKEMIA», 2022, 22, pp. 370 - 371 [articolo]
Lolli, Ginevra; Ursi, Margherita; Dicataldo, Michele; Casadei, Beatrice; Storci, Gianluca; Argnani, Lisa; Bonifazi, Francesca; Zinzani, Pier Luigi, Allogeneic stem cell transplantation is capable of healing a case of bone marrow aplasia following CAR-T cell therapy in a lymphoma patient, «LEUKEMIA & LYMPHOMA», 2022, Epub ahead of print, pp. 1 - 3 [articolo]
Alderuccio, Juan Pablo; Arcaini, Luca; Watkins, Marcus P; Beaven, Anne W; Shouse, Geoffrey; Epperla, Narendranath; Spina, Michele; Stefanovic, Alexandra; Sandoval-Sus, Jose; Torka, Pallawi; Alpert, Ash B; Olszewski, Adam J; Kim, Seo-Hyun; Hess, Brian; Gaballa, Sameh; Ayyappan, Sabarish; Castillo, Jorge J; Argnani, Lisa; Voorhees, Timothy J; Saba, Raya; Chowdhury, Sayan Mullick; Vargas, Fernando; Reis, Isildinha M; Kwon, Deukwoo; Alexander, Jonathan S; Zhao, Wei; Edwards, Dali; Martin, Peter; Cencini, Emanuele; Kamdar, Manali; Link, Brian K; Logothetis, Constantine N; Herrera, Alex F; Friedberg, Jonathan W; Kahl, Brad S; Luminari, Stefano; Zinzani, Pier Luigi; Lossos, Izidore S, An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma, «BLOOD ADVANCES», 2022, 6, pp. 2035 - 2044 [articolo]Open Access
Stefoni V.; Argnani L.; Carella M.; Casadei B.; Morigi A.; Lolli G.; Broccoli A.; Pellegrini C.; Nanni L.; Coppola P.E.; Zinzani P.L., BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma: a real-life experience, «JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY», 2022, Online ahead of print, pp. 1 - 5 [articolo]Open Access
Stefoni, V.; Pellegrini, C.; Argnani, L.; Corradini, P.; Dodero, A.; Orsucci, L.; Volpetti, S.; Zinzani, P. L., Brentuximab vedotin in the treatment of relapsed/refractory CD30+ peripheral T-cell lymphoma: A FIL phase 2 study, «HEMATOLOGICAL ONCOLOGY», 2022, 40, pp. 307 - 309 [articolo]
Zanetti, Anna; Sakellariou, Garifallia; Zambon, Antonella; Carrara, Greta; Argnani, Lisa; Mantovani, Lorenzo G; Cortesi, Paolo A; Bugatti, Serena; Montecucco, Carlomaurizio; Scirè, Carlo A, Cost-effectiveness of the early arthritis clinic organizational model: the ELECTRA study, «ARTHRITIS CARE & RESEARCH», 2022, Epub ahead of print, pp. 1 - 6 [articolo]Open Access
Nanni, Laura; Musuraca, Gerardo; Morigi, Alice; Stefoni, Vittorio; Barone, Monica; Conti, Gabriele; Fabbrini, Marco; Turroni, Silvia; Broccoli, Alessandro; Argnani, Lisa; Brigidi, Patrizia; Zinzani, Pier Luigi, Design of New Personalized Therapeutic Approaches for Diffuse Large B-Cell Lymphoma through Gut Microbiome Profiling, «BLOOD», 2022, 140, pp. 4961 - 4963 [abstract]
Broccoli A.; Terragna C.; Nanni L.; Martello M.; Armuzzi S.; Agostinelli C.; Morigi A.; Casadei B.; Pellegrini C.; Stefoni V.; Sabattini E.; Argnani L.; Zinzani P.L., Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia, «HEMATOLOGICAL ONCOLOGY», 2022, 40, pp. 57 - 62 [articolo]Open Access
Broccoli, A.; Terragna, C.; Nanni, L.; Martello, M.; Armuzzi, S.; Agostinelli, C.; Morigi, A.; Casadei, B.; Pellegrini, C.; Stefoni, V.; Sabattini, E.; Argnani, L.; Zinzani, P. L., Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia, «HEMATOLOGICAL ONCOLOGY», 2022, 40, pp. 57 - 62 [articolo]Open Access
Argnani, Lisa, "First Twin Live-Birth Deliver After Oocyte Cryopreservation in a Follicular Lymphoma Patient", «BIOMEDICAL JOURNAL OF SCIENTIFIC & TECHNICAL RESEARCH», 2022, 41, pp. 0 - 0 [articolo]
Lolli, Ginevra; Casadei, Beatrice; Stefoni, Vittorio; Argnani, Lisa; Bonifazi, Francesca; Zinzani, Pier Luigi, Hepatosplenic T-cell non-Hodgkin lymphoma cured with tandem autologous and allogeneic stem cell transplantation, «CHEMOTHERAPY», 2022, 67, pp. 253 - 255 [articolo]
Argnani, L.; Casadei, B.; Pelusi, C.; Lo Preiato, V.; Pagotto, U.; Bertoni, F.; Zinzani, P. L., Immune-related adverse events in the treatment of non-Hodgkin lymphoma with immune checkpoint inhibitors, «SCIENTIFIC REPORTS», 2022, 12, Article number: 1753, pp. 1753 - 1759 [articolo]Open Access
Carrara G.; Argnani L.; Zanetti A.; Zabotti A.; Silvagni E.; Sebastiani G.D.; Sebastiani M.; Scire C.A., Persistence of bDMARD therapy in Rheumatoid Arthritis after first-line TNF-inhibitor failure: the RECORD study of the Italian Society for Rheumatology, «SCANDINAVIAN JOURNAL OF RHEUMATOLOGY», 2022, Online ahead of print, pp. 1 - 5 [articolo]
Broccoli, Alessandro; Argnani, Lisa; Coppola, Paolo Elia; Gentilini, Marianna; Bagnato, Gianmarco; Lolli, Ginevra; Carella, Matteo; Nanni, Laura; Morigi, Alice; Casadei, Beatrice; Pellegrini, Cinzia; Stefoni, Vittorio; Zinzani, Pier Luigi, Prolonged responses to brentuximab vedotin as last therapy in Hodgkin lymphoma failing autologous transplantation: A case series, «TUMORI», 2022, Online ahead of print, pp. 3008916221090327 - 3008916221090327 [articolo]
Argnani L, Broccoli A, Pellegrini C, Fabbri A, Puccini B, Bruna R, Tisi MC, Masia F, Flenghi L, Nizzoli ME, Musso M, Salerno M, Scalzulli PR, Dessi' D, Ferrarini I, Pennese E, Lucchini E, Rossi FG, Minoia C, Gherlinzoni F, Musto P, Patti C, Stefoni V, Zinzani PL., Real-world Outcomes of Relapsed/Refractory Diffuse Large B-cell Lymphoma Treated With Polatuzumab Vedotin-based Therapy., «HEMASPHERE», 2022, 6, pp. 1 - 5 [articolo]Open Access
